Ensysce Biosciences Inc (ENSC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $7.97M
Last updated: Nov 17, 2026 at 4:10 PM ET
Ensysce Biosciences Inc (ENSC) Stock Chart
Ensysce Biosciences (ENSC) has a latest price of $0.38 on Nov 17, 2026, 80.3% below its 52-week high of $1.95. Its price fell 81.4% over the past 12 months. The month-end price fell 100.0% since Mar 2018, a compound annual decline of 73.2%.
Price Chart
From Mar 2018 to Oct 2026, its highest month-end close was $52,158.79 in Jun 2021 and its lowest $0.25 in Jul 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ENSC with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ENSC.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 1.1%, and over 6 months it rose 29.5%. The month-end price fell 97.0% over the 3 years through Oct 2026, a compound annual decline of 68.8%.
| Period | Change |
|---|---|
| 1 month | -23.7% |
| 3 months | -1.1% |
| 6 months | +29.5% |
| 12 months | -81.4% |
| 12 months, with dividends | -81.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -97.0% | -68.8% |
| 5 years | -100.0% | -86.0% |
| Since Mar 2018 | -100.0% | -73.2% |
Price by Year
Its best calendar year was 2020, when the price rose 19.3%, and its weakest was 2022, when it fell 99.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.42 | -54.2% |
| 2025 | $0.92 | -88.7% |
| 2024 | $8.14 | -48.8% |
| 2023 | $15.89 | -88.2% |
| 2022 | $134.99 | -99.2% |
| 2021 | $16,918.31 | -62.2% |
| 2020 | $44,760.45 | +19.3% |
| 2019 | $37,508.26 | +6.1% |
Trading Range
The price is 13.4% below its 50-day average of $0.44 and 5.1% below its 200-day average of $0.40.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.38 | |
| 52-week high | $1.95 | -80.3% |
| 52-week low | $0.23 | +66.9% |
| 50-day average | $0.44 | -13.4% |
| 200-day average | $0.40 | -5.1% |
Price Risk
Over 3 years, its largest fall from a peak was 99.0%.
| Measure | Value |
|---|---|
| 1-year beta | 1.33 |
| Largest fall, 1 year | -87.2% |
| Largest fall, 3 years | -99.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ENSC
What is ENSC's 1-year price change?
Ensysce Biosciences's price fell 81.4% over the past 12 months. With dividends included, the 12-month total return was -81.4%.
What is ENSC's 5-year price change?
Ensysce Biosciences's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 86.0%. These figures leave out dividends.
What is ENSC's 52-week high and low?
Ensysce Biosciences's 52-week high is $1.95 and its 52-week low is $0.23. Its latest price of $0.38 on Nov 17, 2026 is 80.3% below the high.
What is ENSC's beta?
Ensysce Biosciences's 1-year beta against the S&P 500 is 1.33, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 87.2%.
Is the ENSC chart free?
Yes. Advanced Charting for ENSC is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ENSC pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors